Onset of vitiligo following targeted therapy for BRAFV600E-mutated melanoma: case report

• Κύριοι συγγραφείς: Sonia Brugnara (Συγγραφέας), Mariacristina Sicher (Συγγραφέας), Elena Maria Bonandini (Συγγραφέας), Mattia Barbareschi (Συγγραφέας), Carlo Renè Girardelli (Συγγραφέας), Orazio Caffo (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BioExcel Publishing Ltd, 2019-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Systemic treatment for metastatic melanoma has advanced dramatically in recent years with an impressive increase in the rate of overall survival. The two main different strategies are targeted therapies (i.e. BRAF and MEK inhibitors) and immunotherapy with monoclonal antibodies against the immune ch...